REGISTERED NUMBER: 05649477 (England and Wales)

PHARMACY MATTERS LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30TH JANUARY 2025

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr S J Fec

Mrs J L Fec

REGISTERED OFFICE:

Garth House

High Street

Talgarth

LD3 0PF

REGISTERED NUMBER:

05649477 (England and Wales)

ACCOUNTANTS:

Carston ETL

Tudor House

16 Cathedral Road

Cardiff

CF11 9LJ

FIXED ASSETS

Intangible assets

4

-

-

Tangible assets

5

117,254

117,226

117,254

117,226

CURRENT ASSETS

Stocks

36,657

41,562

Debtors

6

79,478

102,572

Cash at bank and in hand

215,652

157,390

331,787

301,524

CREDITORS

Amounts falling due within one year

7

160,121

117,422

NET CURRENT ASSETS

171,666

184,102

TOTAL ASSETS LESS CURRENT LIABILITIES

288,920

301,328

CREDITORS

Amounts falling due after more than one year

8

(2,514

)

(7,840

)

PROVISIONS FOR LIABILITIES

(6,096

)

(5,237

)

NET ASSETS

280,310

288,251

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

280,210

288,151

SHAREHOLDERS' FUNDS

280,310

288,251

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th January 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th January 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24th October 2025 and were signed on its behalf by:

Mr S J Fec - Director

Mrs J L Fec - Director

1.	STATUTORY INFORMATION

Pharmacy Matters Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Freehold property

-

2% straight line on cost

Fixtures and fittings

-

25% straight line on cost

Motor vehicles

-

25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2024 - 5 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 31st January 2024

and 30th January 2025

100,000

AMORTISATION

At 31st January 2024

and 30th January 2025

100,000

NET BOOK VALUE

At 30th January 2025

-

At 30th January 2024

-

5.	TANGIBLE FIXED ASSETS

Fixtures

Freehold

and

Motor

property

fittings

vehicles

Totals

£

£

£

£

COST

At 31st January 2024

117,757

71,219

24,670

213,646

Additions

-

11,813

-

11,813

Disposals

-

(7,912

)

-

(7,912

)

At 30th January 2025

117,757

75,120

24,670

217,547

DEPRECIATION

At 31st January 2024

28,330

67,833

257

96,420

Charge for year

1,555

4,127

6,103

11,785

Eliminated on disposal

-

(7,912

)

-

(7,912

)

At 30th January 2025

29,885

64,048

6,360

100,293

NET BOOK VALUE

At 30th January 2025

87,872

11,072

18,310

117,254

At 30th January 2024

89,427

3,386

24,413

117,226

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

1,844

950

Other debtors

77,634

101,622

79,478

102,572

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

4,400

4,000

Trade creditors

97,341

100,271

Taxation and social security

14,515

5,962

Other creditors

43,865

7,189

160,121

117,422

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Bank loans

2,514

7,840

9.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30th January 2025 and 30th January 2024:

2025

2024

£

£

Mrs J L Fec

Balance outstanding at start of year

(197

)

(1,945

)

Amounts advanced

-

1,748

Amounts repaid

(20,140

)

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

(20,337

)

(197

)

Mr S J Fec

Balance outstanding at start of year

(197

)

(1,945

)

Amounts advanced

-

1,748

Amounts repaid

(20,140

)

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

(20,337

)

(197

)